# Bone Biologics Corp: filings

BBLG · Nasdaq · CIK 1419554 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bblg.md) · [Financials](/companies/bblg/financials.md) · [Filings](/companies/bblg/filings.md) · [Insiders](/companies/bblg/insiders.md)

## Reports and events: 214 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 102, 8-K 102, 10-Q 55, CORRESP 21, 3 20, 10-K 18, EFFECT 15, UPLOAD 15, S-1/A 11, DEF 14A 10, SC 13G/A 9, SC 13D/A 8, POS AM 7, S-1 7, 424B4 6, SC 13G 6, 424B5 5, NT 10-Q 5, S-3 5, ARS 4, D 4, DEF 14C 4, DEFA14A 4, 4/A 3, PRE 14A 3, PRE 14C 3, S-1MEF 3, S-8 3, NT 10-K 2, S-3/A 2, 10-K/A 1, 25-NSE 1, 424B3 1, 8-A12B 1, 8-K/A 1, CERT 1, D/A 1, DRS 1, DRSLTR 1, SC 13D 1, SCHEDULE 13G 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 17:00 ET | [10-Q](/filings/0001493152-26-048571.md) | Quarterly report, period 2026-09-30 | 0001493152-26-048571 |
| 2026-09-29 | 17:00 ET | [8-K](/filings/0001493152-26-044889.md) | 5.07 Shareholder vote results | 0001493152-26-044889 |
| 2026-09-16 | 17:00 ET | [8-K](/filings/0001493152-26-042940.md) | 3.01 Delisting notice | 0001493152-26-042940 |
| 2026-08-28 | 17:27 ET | [DEF 14A](/filings/0001493152-26-040640.md) | Proxy statement, period 2026-08-28 | 0001493152-26-040640 |
| 2026-08-14 | 17:00 ET | [10-Q](/filings/0001493152-26-038482.md) | Quarterly report, period 2026-06-30 | 0001493152-26-038482 |
| 2026-07-23 | 08:05 ET | [8-K](/filings/0001493152-26-034334.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-034334 |
| 2026-07-16 | 17:25 ET | [8-K](/filings/0001493152-26-033586.md) | 8.01 Other events | 0001493152-26-033586 |
| 2026-07-09 | 16:30 ET | [8-K](/filings/0001493152-26-032694.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-032694 |
| 2026-07-02 | 08:00 ET | [DEF 14A](/filings/0001493152-26-031652.md) | Proxy statement, period 2026-07-02 | 0001493152-26-031652 |
| 2026-05-14 | 17:00 ET | [10-Q](/filings/0001493152-26-023163.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023163 |
| 2026-03-13 | 16:35 ET | [8-K](/filings/0001493152-26-010080.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-010080 |
| 2026-03-02 | 16:35 ET | [10-K](/filings/0001493152-26-008564.md) | Annual report, period 2025-12-31 | 0001493152-26-008564 |
| 2026-01-08 | 08:05 ET | [8-K](/filings/0001493152-26-000896.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-000896 |
| 2025-11-14 | 16:36 ET | [10-Q](/filings/0001493152-25-023563.md) | Quarterly report, period 2025-09-30 | 0001493152-25-023563 |
| 2025-09-04 | 07:05 ET | [8-K](/filings/0001493152-25-012604.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-012604 |
| 2025-08-14 | 16:30 ET | [10-Q](/filings/0001493152-25-011993.md) | Quarterly report, period 2025-06-30 | 0001493152-25-011993 |
| 2025-06-30 | 16:38 ET | [8-K](/filings/0001641172-25-017165.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-017165 |
| 2025-06-26 | 16:35 ET | [8-K](/filings/0001641172-25-016664.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-016664 |
| 2025-06-24 | 16:10 ET | [S-1](/filings/0001641172-25-016289.md) | Registration statement | 0001641172-25-016289 |
| 2025-06-06 | 08:05 ET | [8-K](/filings/0001641172-25-013937.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-013937 |
| 2025-05-30 | 17:00 ET | [8-K](/filings/0001641172-25-013084.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-013084 |
| 2025-05-12 | 17:00 ET | [10-Q](/filings/0001641172-25-009746.md) | Quarterly report, period 2025-03-31 | 0001641172-25-009746 |
| 2025-04-23 | 08:00 ET | [DEF 14A](/filings/0001641172-25-005775.md) | Proxy statement, period 2024-12-31 | 0001641172-25-005775 |
| 2025-04-11 | 17:00 ET | [8-K](/filings/0001641172-25-003880.md) | 3.01 Delisting notice | 0001641172-25-003880 |
| 2025-04-01 | 17:15 ET | [8-K](/filings/0001641172-25-002130.md) | 5.08 Item not in the standard list | 0001641172-25-002130 |
| 2025-02-26 | 17:00 ET | [10-K](/filings/0001493152-25-008383.md) | Annual report, period 2024-12-31 | 0001493152-25-008383 |
| 2024-12-13 | 17:05 ET | [8-K](/filings/0001493152-24-050025.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-050025 |
| 2024-11-14 | 17:00 ET | [10-Q](/filings/0001493152-24-046020.md) | Quarterly report, period 2024-09-30 | 0001493152-24-046020 |
| 2024-10-21 | 08:05 ET | [8-K](/filings/0001493152-24-041710.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-041710 |
| 2024-10-04 | 17:00 ET | [8-K](/filings/0001493152-24-039554.md) | 5.02 Departure or appointment of officers or directors | 0001493152-24-039554 |
| 2024-09-27 | 17:05 ET | [8-K](/filings/0001493152-24-038583.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-038583 |
| 2024-09-19 | 17:00 ET | [8-K](/filings/0001493152-24-037146.md) | 5.07 Shareholder vote results | 0001493152-24-037146 |
| 2024-08-09 | 16:15 ET | [10-Q](/filings/0001493152-24-030982.md) | Quarterly report, period 2024-06-30 | 0001493152-24-030982 |
| 2024-08-08 | 08:00 ET | [DEF 14A](/filings/0001493152-24-030670.md) | Proxy statement, period 2024-08-08 | 0001493152-24-030670 |
| 2024-08-02 | 08:05 ET | [8-K](/filings/0001493152-24-029978.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-029978 |
| 2024-06-20 | 08:05 ET | [8-K](/filings/0001493152-24-024426.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-024426 |
| 2024-05-14 | 16:31 ET | [10-Q](/filings/0001493152-24-019271.md) | Quarterly report, period 2024-03-31 | 0001493152-24-019271 |
| 2024-03-15 | 16:45 ET | [8-K](/filings/0001493152-24-010114.md) | 5.02 Departure or appointment of officers or directors | 0001493152-24-010114 |
| 2024-03-06 | 16:20 ET | [8-K](/filings/0001493152-24-009033.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-009033 |
| 2024-03-01 | 08:05 ET | [8-K](/filings/0001493152-24-008412.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-008412 |
| 2024-02-26 | 16:50 ET | [S-1/A](/filings/0001493152-24-007837.md) | Registration statement, amended | 0001493152-24-007837 |
| 2024-02-23 | 17:09 ET | [S-1/A](/filings/0001493152-24-007706.md) | Registration statement, amended | 0001493152-24-007706 |
| 2024-02-21 | 17:05 ET | [10-K](/filings/0001493152-24-007432.md) | Annual report, period 2023-12-31 | 0001493152-24-007432 |
| 2024-01-30 | 17:09 ET | [S-1](/filings/0001493152-24-004349.md) | Registration statement | 0001493152-24-004349 |
| 2024-01-12 | 17:15 ET | [8-K](/filings/0001493152-24-002233.md) | 8.01 Other events | 0001493152-24-002233 |
| 2024-01-11 | 08:15 ET | [8-K](/filings/0001493152-24-002010.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-002010 |
| 2024-01-10 | 08:15 ET | [8-K](/filings/0001493152-24-001892.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-001892 |
| 2024-01-02 | 17:15 ET | [8-K](/filings/0001493152-24-000132.md) | 5.02 Departure or appointment of officers or directors | 0001493152-24-000132 |
| 2023-12-18 | 08:05 ET | [8-K](/filings/0001493152-23-045193.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-045193 |
| 2023-12-13 | 09:15 ET | [8-K](/filings/0001493152-23-044661.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001493152-23-044661 |

Page 1 of 5. [Older](/companies/bblg/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 17:12 ET. No prices; not investment advice.